Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Interest Coverage Ratio (2022 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Interest Coverage Ratio for 4 consecutive years, with 10.2 as the latest value for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio fell 34.64% to 10.2 in Q4 2025 year-over-year; TTM through Dec 2025 was 9.33, a 27.61% increase, with the full-year FY2025 number at 9.33, up 27.61% from a year prior.
  • Interest Coverage Ratio was 10.2 for Q4 2025 at Rhythm Pharmaceuticals, up from 11.1 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 7.57 in Q3 2024 to a low of 29.42 in Q1 2024.
  • A 4-year average of 12.67 and a median of 10.65 in 2025 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: crashed 71.43% in 2024, then surged 70.46% in 2025.
  • Rhythm Pharmaceuticals' Interest Coverage Ratio stood at 13.98 in 2022, then skyrocketed by 35.14% to 9.07 in 2023, then increased by 16.49% to 7.57 in 2024, then crashed by 34.64% to 10.2 in 2025.
  • Per Business Quant, the three most recent readings for RYTM's Interest Coverage Ratio are 10.2 (Q4 2025), 11.1 (Q3 2025), and 7.79 (Q2 2025).